Regulus Therapeutics Inc.

NASDAQ (USD): Regulus Therapeutics Inc. (RGLS)

Last Price

1.39

Today's Change

-0.01 (0.71%)

Day's Change

1.30 - 1.41

Trading Volume

132,943

Overview

Market Cap

90 Million

Shares Outstanding

65 Million

Avg Volume

363,215

Avg Price (50 Days)

1.54

Avg Price (200 Days)

1.88

PE Ratio

-1.36

EPS

-1.02

Earnings Announcement

20-Mar-2025

Previous Close

1.40

Open

1.41

Day's Range

1.3 - 1.41

Year Range

1.08 - 3.79

Trading Volume

133,043

Price Change Highlight

1 Day Change

-1.07%

5 Day Change

-8.88%

1 Month Change

-7.67%

3 Month Change

-16.06%

6 Month Change

-26.72%

Ytd Change

5.73%

1 Year Change

1.09%

3 Year Change

-61.53%

5 Year Change

-79.02%

10 Year Change

-99.93%

Max Change

-99.73%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 1 of 1 comments

actvtrader

I like the 50.00 price target for yahoo!

2014-10-22 15:48

Post a Comment